Literature DB >> 28581343

Postoperative acute kidney injury following intraoperative blood product transfusions during cardiac surgery.

Bogdan A Kindzelski1, Philip Corcoran1, Michael P Siegenthaler1, Keith A Horvath1.   

Abstract

INTRODUCTION: This study explored the nature of the association between intraoperative usage of red blood cell, fresh frozen plasma, cryoprecipitate or platelet transfusions and acute kidney injury.
METHODS: A total of 1175 patients who underwent cardiac surgery between 2008 and 2013 were retrospectively analyzed. We assessed the association between: (1) preoperative patient characteristics and acute kidney injury, (2) intraoperative blood product usage and acute kidney injury, (3) acute kidney injury and 30-day mortality or re-hospitalization.
RESULTS: In our cohort of 1175 patients, 288 patients (24.5%) developed acute kidney injury. This included 162 (13.8%), 69 (5.9%) and 57 (4.9%) developing stage 1, stage 2 or stage 3 acute kidney injury, respectively. Increased red blood cell, fresh frozen plasma or platelet transfusions increased the odds of developing acute kidney injury. Specifically, every unit of red blood cells, fresh frozen plasma or platelets transfused was associated with an increase in the covariate-adjusted odds ratio of developing ⩾ stage 2 kidney injury of 1.18, 1.19 and 1.04, respectively.
CONCLUSIONS: Intraoperative blood product transfusions were independently associated with an increased odds of developing acute kidney injury following cardiac surgery. Further randomized studies are needed to better define intraoperative transfusion criteria.

Entities:  

Keywords:  acute kidney injury; cardiac surgery; fresh frozen plasma; platelet; red blood cell; transfusions

Mesh:

Year:  2017        PMID: 28581343     DOI: 10.1177/0267659117712405

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  7 in total

1.  Comparison of Patient's Kidney Function Based on Kidney Disease Improving Global Outcomes (KDIGO) Criteria and Clinical Parameters in Isolated Coronary Artery Bypass Graft (CABG) Surgery in On-Pump and Off-pump Methods in Patients with Low Cardiac Output Syndrome (LCOS) After Surgery.

Authors:  Mehdi Fathi; Morteza Valaei; Amene Ghanbari; Reza Ghasemi; Mohsen Yaghubi
Journal:  Anesth Pain Med       Date:  2020-04-19

2.  Effects of perioperative erythropoietin administration on acute kidney injury and red blood cell transfusion in patients undergoing cardiac surgery: A systematic review and meta-analysis.

Authors:  Hyeon Ju Shin; Eunji Ko; Injae Jun; Hyun Jung Kim; Choon Hak Lim
Journal:  Medicine (Baltimore)       Date:  2022-03-04       Impact factor: 1.817

3.  Identification of risk factors for postoperative stage 3 acute kidney injury in patients who received surgical repair for acute type A aortic dissection.

Authors:  Zhigang Wang; Min Ge; Zheyun Wang; Cheng Chen; Lichong Lu; Lifang Zhang; Dongjin Wang
Journal:  BMC Surg       Date:  2022-03-02       Impact factor: 2.102

4.  Risk factors for acute kidney injury after Stanford type A aortic dissection repair surgery: a systematic review and meta-analysis.

Authors:  Lei Wang; Guodong Zhong; Xiaochai Lv; Yi Dong; Yanting Hou; Xiaofu Dai; Liangwan Chen
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 5.  Prevention of Cardiac Surgery-Associated Acute Kidney Injury: A Review of Current Strategies.

Authors:  Kirolos A Jacob; David E Leaf
Journal:  Anesthesiol Clin       Date:  2019-09-21

6.  Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.

Authors:  Michael A Thompson; Jeffrey P Henderson; Pankil K Shah; Samuel M Rubinstein; Michael J Joyner; Toni K Choueiri; Daniel B Flora; Elizabeth A Griffiths; Anthony P Gulati; Clara Hwang; Vadim S Koshkin; Esperanza B Papadopoulos; Elizabeth V Robilotti; Christopher T Su; Elizabeth M Wulff-Burchfield; Zhuoer Xie; Peter Paul Yu; Sanjay Mishra; Jonathon W Senefeld; Dimpy P Shah; Jeremy L Warner
Journal:  JAMA Oncol       Date:  2021-06-17       Impact factor: 33.006

Review 7.  CSA-AKI: Incidence, Epidemiology, Clinical Outcomes, and Economic Impact.

Authors:  Alan Schurle; Jay L Koyner
Journal:  J Clin Med       Date:  2021-12-08       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.